Ekso Bionics Holdings, Inc. (EKSO)
11.44
+0.23
(+2.05%)
USD |
NASDAQ |
Apr 29, 16:00
11.52
+0.08
(+0.70%)
After-Hours: 20:00
Ekso Bionics Holdings EPS Diluted (Quarterly) : -1.568 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -0.0219 |
| Abbott Laboratories | 0.6165 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1428 |
| Plus Therapeutics, Inc. | -1.03 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.674M |
| Revenue (Quarterly) | 3.14M |
| Total Expenses (Quarterly) | 7.814M |
| Enterprise Value | 44.24M |
| Gross Profit Margin (Quarterly) | 53.22% |
| Profit Margin (Quarterly) | -148.9% |
| Earnings Yield | -30.31% |
| Normalized Earnings Yield | -30.31 |